Metabolic syndrome: a psychiatric outlook - Publication - Bridge of Knowledge

Search

Metabolic syndrome: a psychiatric outlook

Abstract

Citations

  • 0

    CrossRef

  • 0

    Web of Science

  • 0

    Scopus

Cite as

Full text

download paper
downloaded 13 times
Publication version
Submitted Version
License
Creative Commons: CC-BY-NC-ND open in new tab

Keywords

Details

Category:
Other publications
Type:
Other publications
Title of issue:
Psychosomatic Medicine Research
Publication year:
2023
DOI:
Digital Object Identifier (open in new tab) 10.53388/psmr2023001
Bibliography: test
  1. De Hert M, Cohen D, Bobes J, et al. Physical illness in patients Submit a manuscript: https://www.tmrjournals.com/psmr with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011;10(2):138-151. http://doi.org/10.1002/j.2051-5545.2011.tb00036.x open in new tab
  2. De Hert MA, van Winkel R, Van Eyck D, et al. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res 2006;83(1):87-93. http://doi.org/10.1016/j.schres.2005.12.855 open in new tab
  3. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, et al. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes care 2004;27(2):596-601. http://doi.org/10.2337/diacare.27.2.596 open in new tab
  4. Vancampfort D, Stubbs B, Mitchell AJ, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 2015;14(3):339-347. http://doi.org/10.1002/wps.20252 open in new tab
  5. Meyer J, Koro CE, L'Italien GJ. The metabolic syndrome and schizophrenia: a review. Int Rev Psychiatry 2005;17(3):173-180. http://doi.org/10.1080/09540260500071798 open in new tab
  6. Thakore JH. Metabolic syndrome and schizophrenia. Br J Psychiatry 2005;186(6):455-456. open in new tab
  7. http://doi.org/10.1192/bjp.186.6.455 open in new tab
  8. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005;7(5):424-430. open in new tab
  9. http://doi.org/10.1111/j.1399-5618.2005.00234.x 8. Heiskanen TH, Niskanen LK, Hintikka JJ, et al. Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry 2006;67(9):1422-1427. open in new tab
  10. http://doi.org/10.4088/JCP.v67n0913 open in new tab
  11. Vieweg WVR, Julius DA, Fernandez A, Tassone DM, Narla SN, Pandurangi AK. Posttraumatic stress disorder in male military veterans with comorbid overweight and obesity. Prim Care Companion J Clin Psychiatry 2006;8(1):25-31. http://doi.org/10.4088/PCC.v08n0104 open in new tab
  12. Muldoon MF, Mackey RH, Korytkowski MT, Flory JD, Pollock BG, Manuck SB. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers. J Clin Endocrinol Metab 2006;91(2):718-721. http://doi.org/10.1210/jc.2005-1654 open in new tab
  13. Aronne LJ. Epidemiology, morbidity and treatment of overweight and obesity. J Clin Psychiatry 2001;62:13-22. https://pubmed.ncbi.nlm.nih.gov/11603881/
  14. McIntyre RS, Mancini DA, Basile VS. Mechanisms of antipsychotics-induced weight gain. J Clin Psychiatry 2001;62:23-29. https://pubmed.ncbi.nlm.nih.gov/11603882/ open in new tab
  15. Connolly M, Kelly C. Lifestyle and physical health in schizophrenia. Adv psychiatr treat 2005;11(2):125-132. http://doi.org/10.1192/apt.11.2.125 open in new tab
  16. Ho CSH, Zhang MWB, Mak A, Ho RCM. Metabolic syndrome in psychiatry: advances in understanding and management. Adv psychiatr treat 2014;20(2):101-112. http://doi.org/10.1192/apt.bp.113.011619 open in new tab
  17. Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One 2014;9(4):e94112. http://doi.org/10.1371/journal.pone.0094112 open in new tab
  18. Correll CU, Detraux J, Lepeleire JD, Hert MD. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14(2):119-136. http://doi.org/10.1002/wps.20204 open in new tab
  19. Reynolds GP, McGowan OO. Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment. J Psychopharmacol 2017;31(11):1430-1436. http://doi.org/10.1177/0269881117722987 open in new tab
  20. Siddiqui J, Qureshi S, Ahmed Shawosh Y. Clozapine-induced massive hematemesis: a rare case report. Ann Indian Psychiatry 2019;3(2):171. http://doi.org/10.4103/aip.aip_8_19 open in new tab
  21. McIntyre RS, Mancini DA, Basile VS. Mechanisms of antipsychotics-induced weight gain. J Clin Psychiatry 2001;62:23-29. https://pubmed.ncbi.nlm.nih.gov/11603882/ open in new tab
  22. Lindenmayer JP, Nathan AM, Smith RC. Hyperglicemia associated with the use of atypical antipsychotics. J Clin Psychiatry 2001;23:30-38.
  23. Henderson DC. Schizophrenia and commorbid metabolic disorders. J Clin Psychiatry 2005;6:11-20. open in new tab
  24. Samyukta K, Shivson D, Kantipudi SJ. Effect of Olanzapine on metabolic syndrome-a one year follow-up study. J Clin Diagnostic Res 2020;14(6):VC01-VC04. http://doi.org/10.7860/JCDR/2020/44521.13773 open in new tab
  25. Padmavati R, McCreadie RG, Tirupati S. Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia. Schizophr Res 2010;121(1-3):199-202. open in new tab
  26. http://doi.org/10.1016/j.schres.2010.05.010 open in new tab
  27. Meyer JM, Davis VG, Goff DC, et al. Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE schizophrenia trial: prospective data from phase 1. Schizophr Res 2008;101(1-3):273-386. http://doi.org/10.1016/j.schres.2007.12.487 open in new tab
  28. Chokka P, Tancer M, Yeragani VK. Metabolic syndrome: relevance to antidepressant treatment. J Psychiatry Neurosci 2006;31(6):414. https://pubmed.ncbi.nlm.nih.gov/17136222/
  29. Attvall S, Fowelin J, Lager I, Schenck H, Smith U. Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J Intern Med 1993;233(4):327-332. http://doi.org/10.1111/j.1365-2796.1993.tb00680.x open in new tab
  30. Jelski W, Szmitkowski M. Effect of ethanol on metabolic syndrome. Pol Arch Intern Med 2007;117(7):306-311. http://doi.org/10.20452/pamw.164 open in new tab
  31. Björntorp P, Rosmond R. The metabolic syndrome -a neuroendocrine disorder? Br J Nutr 2000;83(S1):S49-S57. http://doi.org/10.1017/S0007114500000957 open in new tab
  32. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998;55(7):580. http://doi.org/10.1001/archpsyc.55.7.580 open in new tab
  33. Howren MB, Lamkin DM, Suls J. Associations of depression with c-reactive Protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71(2):171-186. open in new tab
  34. http://doi.org/10.1097/PSY.0b013e3181907c1b open in new tab
  35. Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Current Science Inc 2008;10(2):131-137. http://doi.org/10.1007/s11906-008-0025-y open in new tab
  36. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RSJ, Dolan RJ. The anatomy of melancholia -focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992;22(3):607-615. open in new tab
  37. http://doi.org/10.1017/S003329170003806X open in new tab
  38. Chang HH, Chou CH, Chen PS, et al. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord 2009;117(1-2):124-129. http://doi.org/10.1016/j.jad.2008.12.018 open in new tab
  39. Weber M, Wyne K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res 2006;83(1):95-101. http://doi.org/10.1016/j.schres.2006.01.008 open in new tab
  40. De Hert M, Schreurs V, Vancampfort D, Van Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009;8(1):15-22. http://doi.org/10.1002/j.2051-5545.2009.tb00199.x open in new tab
  41. Nauck MA. Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications. Am J Med 2011;124(1):S3-S18. open in new tab
  42. http://doi.org/10.1016/j.amjmed.2010.11.002 open in new tab
  43. Blackburn GL, Hutter MM, Harvey AM, et al. Expert panel on weight loss surgery: executive report update. Obesity 2009;17(5):842-862. open in new tab
  44. http://doi.org/10.1038/oby.2008.578 open in new tab
Verified by:
No verification

seen 33 times

Recommended for you

Meta Tags